TGFB1 and metabolic dysfunction-associated steatotic liver disease: RNASeq analysis showed that both TNFa and TGFβ signaling pathways contribute to the development of fibrosis and inflammation, confirming that decreased lipogenesis may have a role in liver damage and MASLD progression [47].